Insiders Updates
EWTX’s short interest falls to 8.57 million shares
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Edgewise Therapeutics
Menu
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Edgewise Therapeutics
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Edgewise Therapeutics Inc’s recent filing unveils that its Chief Scientific Officer Russell Alan J unloaded Company’s shares for reported $1.46
Edgewise Therapeutics Inc’s recent filing unveils that its Chief Scientific Officer Russell Alan J unloaded Company’s shares for reported $1.46
Edgewise Therapeutics Inc’s filing revealed that its Chief Scientific Officer Russell Alan J unloaded Company’s shares for reported $1.46 million
Edgewise Therapeutics Inc’s recently made public that its Chief Scientific Officer Russell Alan J unloaded Company’s shares for reported $1.46
Edgewise Therapeutics Inc’s filing revealed that its General Counsel MOORE JOHN R unloaded Company’s shares for reported $28097.0 on Aug
In a filing, Edgewise Therapeutics Inc revealed its General Counsel MOORE JOHN R unloaded Company’s shares for reported $28097.0 on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Edgewise Therapeutics Inc’s filing revealed that its Chief Scientific Officer Russell Alan J unloaded Company’s shares for reported $25520.0 on